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Adenovirus-mediated gene transfer to renal glomeruli in rodents. virus complexes [11, 12]. Successful gene transfer has
Background. The expression of foreign genes into renal glo- been achieved in vivo in several renal cell types using
merular cells holds enormous potential to modulate the out- different delivery routes and animal models [5–15]. Eachcome of renal diseases. Recombinant adenoviruses (rAds) are
of these vector systems and delivery routes has its strengthspromising gene transfer vectors because they have the ability
and weaknesses, which have been discussed in excellentto infect a wide range of nondividing cells. However, despite
the fact that renal glomeruli are easily accessible via the renal reviews written by other investigators [16–22].
circulation, adenovirus-mediated gene transfer into rodent glo- The expression of foreign genes into renal glomerular
meruli has been problematic. Here, we described our experi- cells holds enormous potential to modulate the outcomeence using rAd vectors to express foreign genes in rodent renal
of renal diseases. Recombinant adenoviruses (rAds) areglomeruli in vivo and in cultured human renal glomerular cells.
promising gene transfer vectors because they have theMethods. We developed two techniques—the “portal clamp-
ing” and “prolonged renal infusion”—to infect mouse and rat ability to infect a wide range of nondividing cells. How-
renal glomeruli in vivo, respectively. We used E-1-deleted rAd ever, despite the fact that renal glomeruli are easily ac-
vectors carrying the lacZ gene encoding -galactosidase (Ad.
cessible via the renal circulation, adenovirus-mediatedCBlacZ) under the control of the cytomegalovirus enhancer
gene transfer into rodent glomeruli has been problem-and chicken -actin promoter. Cultured human renal glomeru-
lar podocytes, endothelial and mesangial cells were grown fol- atic. This article presents our experience using adenovi-
lowing standard techniques. Transgene expression was evaluated ral vectors to transfer foreign genes into rodent renal
by doing -galactosidase staining and reverse transcription- glomeruli and cultured human renal glomerular cells.
polymerase chain reaction studies.
We describe two techniques that can be used as a power-Results. We found that both a prolonged exposure and a
ful tool to study the effects of specific genes in rodenthigh concentration of circulating adenoviral vectors were re-
quired to achieve efficient gene transfer to renal glomerular renal glomerular cells in vivo.
cells in rodents. The virus-mediated transgene expression in
renal glomeruli lasted for at least 42 days in mice and 21 days
in rats without causing significant renal injury. METHODS
Conclusions. These data demonstrate the feasibility of using
Animals and rAdrAd vectors as a tool to express foreign genes in rodent renal
glomerular cells and suggest that all types of human renal All animal experiments were performed following the
glomerular cells are equally susceptible to rAd infection. IACUC guidelines, and animal protocols were approved
by the Children’s Research Institute. Male adult B6/129
F1 mice were purchased from the Jackson Laboratory
During the past years, in vivo gene transfer technology (Bar Harbor, ME, USA). Male Sprague-Dawley rats
has advanced considerably. Efficient gene transfer has (100 to 150 g) were purchased from Taconic (German-
been achieved in various tissues with viral or nonviral town, NY, USA). The E1-deleted rAd carrying the Es-
vectors or even with “naked” DNA [1–4]. Over the past cherichia coli lacZ gene encoding -galactosidase (desig-
few years, a number of attempts have been made to de- nated Ad.CBlacZ) was generated as described [23]. The
liver foreign genes into kidney tissues using a variety of lacZ gene expression was controlled by the cytomegalo-
vectors, including retroviruses [5], adenoviruses [6–8], virus enhancer and chicken -actin gene promoter [23].
adeno-associated virus [9], liposomes [10], and liposome-
Clamping of hepatic artery and portal vein in mice
(portal clamping)Key words: recombinant adenoviruses, Ad.CBlacZ, gene transfer, glo-
meruli. The portal clamping procedure was performed as pre-
viously described [24]. Briefly, mice were anesthetized 2002 by the International Society of Nephrology
S-16
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with an intraperitoneal injection of Ketamine (70 mg/kg) Cell cultures
and Xylazine (7 mg/kg). A laparotomy was performed to Primary human glomerular endothelial cells were a
expose the liver and portal vein. The portal triad (in- generous gift from Dr. Carl Soderland (Applied Cell
cluding portal vein, hepatic artery, and bile duct) was Biology Research Institute, Seattle, WA, USA). These
temporarily closed with a microvascular clamp approxi- cells were positive for expression of von Willebrand fac-
mately 2 to 3 mm below the liver edge (where the portal tor (vWF) and were grown in the endothelial cell culture
vein and hepatic artery enter the liver). The clamp was medium from Cell Systems (Seattle, WA, USA) con-
released 30 minutes later. The abdominal wall was closed taining recombinant human epidermal growth factor
with a 5.0 suture, and the animal was returned to its cage (10 ng/mL), bovine brain extract, heparin (10 g/mL),
after recovering from anesthesia. amphotericine B (50 ng/mL), gentamycin (50 g/mL),
and 5% fetal bovine serum. Human glomerular podo-
Prolonged renal infusion of adenovirus in rats ctyes were isolated from renal glomeruli derived from a
kidney considered unsuitable for transplantation. Briefly,The prolonged renal infusion technique procedure was
the renal cortex was minced into 1 mm fragments anddone as previously described [25]. Briefly, rats were in-
passed through graded series of metal sieves. The re-jected intramuscularly with 20,000 units of penicillin, an-
sulting material containing approximately 95% glomer-esthetized with Ketamine (70 mg/kg, intraperitoneally)
uli by microscopic examination was incubated with colla-and Xylazine (7 mg/kg, intraperitoneally), and underwent
genase (type IV; Sigma, St. Louis, MO, USA) at 37C forsurgical exposure of the right kidney, the aorta, and the
15 minutes. Glomeruli were then pelleted, resuspendedright renal blood vessels. The right renal blood flow was
in culture media, and seeded on different culture dishesinterrupted by clamping the aorta above and below the
as previously described [26]. Colonies of glomerular epi-right renal artery and the superior mesenteric artery
thelial cells (GECs) were selected using cloning rings,(SMA). This setting selectively allowed infusion of virus
whereas all other cells attached to the culture dishesinto the right kidney through the SMA excluding the
were discarded using a cell scraper. GECs were grownleft kidney. A 27-gauge winged infusion needle was in-
in culture media KGM2-BulleKit from Clonetics (Bio-serted into the SMA and fixed in place with a micro-
Whittaker Inc., Walkersville, MD, USA). Expanded col-aneurism clamp; 1.5 mL of Ad.CBlacZ [1  1011 or 5 
onies of GEC that showed positive immunostaining with1011 particle/mL in phosphate-buffered saline (PBS) con-
a monoclonal antibody against the podocyte-specific an-taining 5 units of heparin/mL] were slowly infused into
tigen GLEEP-1 (generously provided by Dr. Roger Wig-the right kidney with a Razel A-99 syringe pump at a
gins, Ann Arbor, MI, USA) and positive staining with anflow rate of 0.1 mL/min. The right kidney was packed
antibody against WT-1 (Dako, Copenhagen, Denmark)with ice during the infusion to minimize ischemic dam-
were used for the infection studies. Human mesangial cellsage. The contralateral left kidney was used as an inter-
(HMCs) were isolated from renal glomeruli, as we havenal negative control. Renal circulation was re-established
previously described [26, 27]. Mesangial cells showed a
at the end of infusion. The animals were sacrificed at
polygonal shape, stained positive for  actin using Bo-
days 3 and 21 postviral infusion (p.i.). Gene transfer ef- dipy-phallacidin (Molecular Probes, Eugene, OR, USA),
ficiency was determined by detecting lacZ staining in lacked the close cell–cell contact typical of endothelial
tissue sections. cells or epithelial cells, and formed ridge composed of
multiple layers of cells surrounding regions of mono-Determination of -galactosidase (lacZ) activity in
layers. HMCs did not stain positive with anticytokeratintissue samples and cell cultures
or antihuman vWF antibodies (Dako) but did stain posi-
Renal cells and frozen renal sections (10 m) were tive with an antimyosin antibody (Zymed, South San
fixed in 0.5% glutaraldehyde at room temperature for Francisco, CA, USA). Finally, HMCs expressed a high
10 minutes, washed with PBS, and stained for 2 hours at number of angiotensin II (Ang II) type 1 receptors (Bmax
37C in PBS containing 5 mmol/L K3Fe(CN)6, 5 mmol/L of approximately 70 fmol/105 cells) and contracted in
K4Fe(CN)6, 1 mmol/L MgCl2, and 1 mg/mL 5-bromo-4- response to Ang II (100 nmol/L) when seeded onto the
chloro-3-indolyl--D-galactopyranoside (X-gal). The tis- surface of a silicone rubber substratum. Renal urinary
sue sections were counterstained with hematoxylin and tubular epithelial cells (RUTEcs) were derived from a
mounted for microscopic evaluation. LacZ staining was child with HIV-1–associated nephropathy (HIVAN).
evaluated by counting lacZ-positive cells in 10 micro- These cells were isolated, cultured, and characterized as
scopic fields using a10 lens. Renal histology was evalu- we have previously described [28, 29]. RUTEc stained
ated independently by two investigators in a blinded positive with a cytokeratin antibody and showed nega-
fashion in renal sections subjected to hematoxylin and tive staining with antibodies against the following: WT-1,
GLEEP, and vWF. RUTEcs were cultured in REGMeosin, periodic acid-Schiff, and Masson stainings.
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BulleKit culture media from Clonetics. All cells were after 30 minutes, and the virus load started to decrease
immediately at a rate similar to that found in mice notused between passages 2 to 4. To determine the suscepti-
bility of each cell type to adenoviral infections, the endo- subjected to the liver-bypass procedure [24].
To determine the effect of prolonged virus circulationthelial cell culture medium was used for all cell types.
Our preliminary data showed that this culture medium on the transduction efficiency in the kidney tissues, B6/
129 F1 mice were subjected to portal clamping immedi-supported the growth of all human cell types used in this
study. ately followed by a retro-orbital injection of Ad.CBlacZ
(2  1011 particle/mouse). The clamp was released after
Adenovirus infection of cultured cells 30 minutes. In animals receiving viruses and subjected
to liver bypass, high levels of lacZ expression were de-The cells were plated in six-well culture dishes at a
density of 5  105 cells/well. rAds were added to the cul- tected at day 3 p.i. in the kidney (Fig. 1A). The transgene
expression was confined to glomerular capillaries andture medium 24 hours later at a multiplicity of infection
(MOI) of 0.4, 4, and 40 plaque forming units (pfu)/cell. mostly in vascular endothelial cells. The expression was
still detectable at day 42 p.i., although the number ofThe cells were fixed 24 hours after the infection and
stained for lacZ activity as described previously in this lacZ-positive structures diminished compared with renal
sections obtained three days after the initial injectionarticle.
(Fig. 1C). Improved lacZ expression was also observed
Reverse transcriptase-polymerase chain reaction in the vasculature of lung and intestine. In control ani-
mals that received viral injection without using the portalTotal kidney RNA was extracted using the TRIzol
reagent (Life Technologies, Grand Island, NY, USA), clamping technique, there was only sporadic lacZ stain-
ing in interstitial cells and vessels surrounding renal tu-reverse transcribed to cDNA using the SuperScript RT
system (Life Technologies), and amplified by polymerase bules at day 3 p.i., which became undetectable by day
42 p.i. (Fig. 1 B, D). High levels of lacZ expressionchain reaction (PCR) using a pair of lacZ-specific prim-
ers for 30 cycles (94C for 30 seconds, 55C for 30 sec- were detected in the liver of all animals at day 3 p.i.,
independently of whether these animals were subjectedonds, and 72C for 45 seconds). The lac Z primers se-
quences were as follows: 5-primer, GATAACGACAT to the liver clamping procedure. However, in both groups
of mice infected with or without using the portal clampTGGCGTAAGTGAAGC, and 3-primer, ATGTGCC
TTCTTCCGCGTGCAGCAGA. technique, less than 3% of liver cells continued to express
lacZ 42 days after the initial infusion. Moreover, at thisThe primer pair amplifies a 579 bp fragment from lacZ
cDNA. Because the primers will also amplify the lacZ stage, mice infected without using the portal clamping
technique did not show significant glomerular lacZ stain-sequences in Ad.CBlacZ, control reactions were set up
using RNA samples without reverse transcriptase (RT) ing. Taken together, these findings suggest that the con-
tinuous renal expression of lacZ in mice infected usingreaction.
the portal clamping technique is not likely to be due to
enhanced renal uptake of lacZ produced in the liver and
RESULTS
trapped in renal glomeruli.
Gene transfer to mouse glomeruli using portal To confirm that the positive lacZ staining in the glo-
clamping technique meruli of mice receiving portal clamping was the result
of virus-mediated -galactosidase expression within glo-First, we carried out experiments to determine whe-
ther mouse renal glomerular cells could be infected by merular cells, we performed RT-PCR analysis on total
kidney RNA extracted from mice receiving Ad.CBlacZa prolonged exposure to rAd vectors. Because infused
rAds are cleared rapidly from the blood circulation by with or without portal clamping. As shown in Figure 2,
-galactosidase-specific signals were detected in the kid-the liver [30–34], we attempted to extend the exposure
time of renal glomerular cells to adenovirus by excluding ney RNA sample from a mouse receiving the virus with
portal clamping (lane 2) but not in samples from anthe liver circulation. The portal vein and hepatic artery
in B6/129 F1 mice were clamped, and an E1-deleted rAd unclamped mouse (lane 4). Lanes 1 and 3 in Figure 2
show control kidney samples from mice infected with orcarrying the -galactosidase gene (Ad.CBlacZ, 2  1011
particle/mouse) was then administered through the retro- without using the portal clamping technique, respec-
tively, but not subjected to reverse transcription.orbital venus plexus. We found that the plasma virus
concentration remained at stable levels as long as the
Gene transfer to rat glomeruli using the “prolongedliver circulation was excluded. In contrast, plasma virus
renal-infusion” techniqueload in animals without liver bypass dropped rapidly
within minutes of viral administration and decreased by In a previous study [25], we described how to infect rat
renal glomerular cells using a “prolonged renal-infusion”more than 10,000-fold 60 minutes after viral injection.
In another group of animals, the clamp was released technique. Briefly, we clamped off the rat aorta below
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Fig. 1. Adenovirus-mediated lacZ expres-
sion in mouse glomerular cells. B6/129 mice
were injected with Ad.CBlacZ (2  1011 parti-
cle/mouse) with or without using the portal
clamping technique. The animals were sacri-
ficed at 3- and 42-days postinfusion. The kid-
neys were harvested, fixed, and stained for
lacZ expression. (A and C ) Representative
renal sections from mice infused with Ad.
CBlacZ and subjected to the portal clamping
procedure at days 3 and 42 postinfusion, re-
spectively. (B and D) Renal sections from
mice that were infused with Ad.CBlacZ with-
out being subjected to the portal-clamping
technique, at days 3 and 42 postinfusion, re-
spectively. Magnification 40.
chemic injury. Two viral doses (1.5  1011 and 7.5  1011
particles/rat) were tested under two different perfusion
conditions (5 and 15 minutes). Effective gene transfer
to kidney was achieved only in animals receiving a 15-
minute infusion at the higher viral dose. LacZ expression
in the infused kidney (right kidney) was limited within
the glomeruli and occasionally in the endothelial cells
of blood vessels. The percentage of glomeruli expressing
the lacZ gene varied from 30 to 70% among treated
animals. An examination of the kidney sections at a
higher magnification showed that the glomerular endo-
thelial cells were clearly positive. However, in renal sec-
tions showing high levels of lacZ expression, we could not
exclude the possibility that mesangial cells or glomerular
podocytes were infected as well. The adenovirus-medi-
ated lacZ expression in the glomeruli was still detectable
Fig. 2. RT-PCR analysis of lacZ expression in mouse kidney. B6/129 at day 21 p.i., although the intensity of -gal staining and
mice were injected with Ad.CBlacZ with or without using the portal the number of lacZ-positive glomeruli were significantly
clamping technique. The animals were sacrificed at day 3 postinfusion.
decreased compared with day 3 samples. LacZ expres-The kidney RNA were extracted and subjected to RT-PCR analysis
using lacZ-specific primers as described in the Methods section. Lanes sion was also observed in the liver of all animals sub-
1 and 2 show results obtained with kidney RNA from a representative jected to the prolonged renal infusion technique, indicat-mouse subjected to the portal-clamping procedure and infused with
ing that hepatocytes were infected by viruses present inAd.CBlacZ. Lanes 3 and 4 show kidney RNA from a representative
mouse that was infused with Ad.CBlacZ without being subjected to the circulation. However, no lacZ expression was de-
the portal clamping technique. Because the lacZ primers sequences tected in the contralateral kidney in all infused animals,described in the Methods section also amplify the lacZ sequence in
Ad.CBlacZ, control samples were done using kidney RNA samples not suggesting that the positive glomerular lacZ staining
subjected to the reverse transcription reaction (negative signs, lanes 1 observed in the perfused kidney was the result of a virus-
and 3).
mediated, in situ lacZ expression, rather than -galacto-
sidase released into the circulation by infected hepato-
cytes and trapped in renal glomeruli.
and above the renal artery and SMA and slowly infused
In vitro gene transfer to human renal cellsa lacZ-containing virus solution into the right kidney
To determine whether cultured human glomerular cellsthrough the SMA using a syringe pump. During the in-
fusion, the kidney was packed with ice to minimize is- could be infected with Ad vectors, we tested the suscepti-
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Fig. 3. Susceptibility of human kidney cells to ade-
noviral infection. Human renal glomerular and tu-
bular cells were plated in six-well culture dishes at
a density of 5  105 cells/well, as described in the
Methods section. rAds (Ad.CBlacZ) were added
to the culture medium 24 hours later. All cells were
grown under identical tissues culture conditions, as
described in the Methods section, fixed 24 hours
after the infection, and stained for -gal activity.
Pictures demonstrating representative results are
shown in the panels. (A–D) Glomerular podocytes
infected at an MOI of 0, 0.4, 4, or 40 pfu/cell, respec-
tively. (E–H ) Renal glomerular endothelial cells
infected at an MOI of 0, 0.4, 4. or 40 pfu/cell, respec-
tively. (I–L) Mesangial cells infected at an MOI of
0, 0.4, 4, or 40 pfu/cell, respectively. (M–P) RUTEcs
infected at an MOI of 0, 0.4, 4 or 40 pfu/cell, respec-
tively. Magnification 100.
bility of different human glomerular cell types to adeno- elements in the nucleus of the host cell [35]. rAd vectors
can be generated by replacing the E1 gene, which is es-viral infection in vitro. Human glomerular endothelial,
podocytes, and mesangial cells, as well as RUTEcs, were sential for viral replication, with the gene of interest and
an enhancer/promoter element. These vectors are beingcultured at approximately 80% confluency and were in-
fected with Ad.CBlacZ at MOIs ranging from 0.4 to 40.0. widely used for gene delivery in vivo. They can effec-
tively infect quiescent or terminally differentiated cellsThe cells were fixed 24 hours later and were stained for
lacZ expression. As shown in Figure 3, all glomerular cell through a specific interaction between the viral fiber
protein and at least one cell surface receptor, the cox-types appeared to be equally susceptible to adenoviral
sakie and adenovirus receptor [36, 37]. Entry of the virusinfection, with a transduction efficiency of 50% at MOI
into the cell is further enhanced through a specific inter-of 4 (Fig. 3 A–L). RUTEcs, required an MOI of approxi-
action of the fiber with an integrin “co-receptor” [38].mately 40 to reach 50% transduction (Fig. 3 M–P).
Cells infected with rAd can express the transgene, but
because essential genes for viral replication are deleted,
DISCUSSION the virus should not replicate. The virus also has distinct
In this study, we describe two procedures, the “portal advantages of high titers and the highest level of trans-
clamping” and “prolonged renal infusion” techniques, gene expression among the available viral vectors. The
which can be used to express foreign genes into rodent disadvantages of adenoviral vectors include the transient
renal glomerular cells in vivo. In addition, we demon- nature of transgene expression due to the lack of integra-
strate that all cultured human renal glomerular cells are tion and the significant immune response to the viral
equally susceptible to the infection with rAd vectors proteins.
carrying the lacZ gene. These findings suggest that ro- Moullier et al provided the first report of an adenovi-
dents could be used as a small animal model system to ral-mediated gene transfer into a kidney in vivo [6]. A
study the in vivo effects of foreign gene transfer into replication deficient adenoviral vector that contained a
renal glomerular cells. lacZ reporter gene was selectively perfused into the renal
The adenoviruses are a family of DNA viruses that artery or infused through a retrograde catheter into the
can infect both dividing and nondividing cells. They are pyelic cavity of the adult rat kidney. Transient (2 to 4
double-stranded linear DNA viruses of approximately weeks), low levels of lacZ expression were observed in
30 to 35 kb in length. The adenoviral genomes contain the proximal tubular cells when the adenoviral vector
was selectively perfused via the renal artery, whereasover a dozen genes, and they are replicated as episomal
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expression was observed in tubular cells from the papilla sion within glomerular cells, we performed RT-PCR analy-
sis on total kidney RNA extracted from these mice. Theseand medulla when the adenoviral vector was adminis-
tered by retrograde infusion. Surprisingly, no transgene experiments clearly demonstrate that lacZ was expressed
in the kidney as early as three days after the initial viralexpression was observed in renal glomerular cells. Sub-
sequently, Zhu et al reported adenovirus-mediated gene infusion. However, given the sensitivity of the RT-PCR
detection system, we cannot exclude the possibility that intransfer to normal rat kidney by infusing the virus into
renal artery followed with cross-clamping and a cold addition to the local renal synthesis, lacZ produced else-
where could be also accumulated in the kidney. Never-incubation to prolong contact time of the adenovirus
while limiting ischemic injury [7]. Gene transfer occurred theless, the absence of significant lacZ staining in renal
glomeruli from mice treated under similar conditions,predominantly in the large blood vessels in the cortex
as well as the periglomerular and peritubular interstitial but injected without using the portal clamping technique,
suggests that lacZ produced elsewhere was not the ma-elements. Once again, the glomerular capillaries were not
stained. When vasodilators were added during the viral jor mechanism responsible for the positive staining in
renal glomeruli.infusion, gene transfer was shifted to the outer medulla
in both the inner and outer stripe. Successful gene trans- In subsequent studies, we developed a prolonged renal
infusion protocol [25] to determined whether rat renalfer to glomeruli was first achieved by Heikkila et al in
a pig model [8]. After failing to infect kidney cells with glomerular cells could be infected with rAd vectors. The
larger blood vessel size in rats makes it possible to infusesingle or multiple injections of adenovirus into the renal
artery, Heikkila et al perfused the kidney with the virus the virus directly into the kidney. Our results show that a
successful infection of rat renal glomerular cells requiresfor two hours using a closed-circuit perfusion system.
Marked glomerular expression was noted in podocytes infusion of an effective amount of adenovirus (7.5 
1011 particles) for a sufficient period of time (15 min-three days after the perfusion. Some expression was ob-
served in other vascular endothelial cells, but none was utes) [25]. These findings, in the context of a previous
study [7], suggest that the virus needs to be actively passingfound in cells of the Bowman’s capsule or renal tubules.
Overall, all these studies suggest that an increased through the glomerular structure to achieve efficient in-
fection. The histologic examination of renal sections atexposure time of renal glomeruli to the virus is necessary
for efficient gene transfer to renal glomerular cells. Based days 3 and 21 after infusion did not reveal significant
signs of glomerular or interstitial injury [25]. Finally, theon this notion, we developed two techniques, “portal
clamping” and “prolonged renal infusion,” to determine absence of lacZ staining in the contralateral left kidney,
which is excluded from the viral injection in our infusionwhether renal glomerular cells from mice or rats, respec-
tively, could be transduced with rAd in vivo. Because protocol, supports the notion that lacZ is produced in
renal glomerular cells.previous studies have shown that rAds administered sys-
temically are cleared rapidly from the blood circulation A concern with the use of the portal clamping or pro-
longed renal infusion techniques is the spreading of circu-by the liver [30–34], we first hypothesized that by by-
passing the hepatic circulation we would maintain a high lating adenovirus to the liver, which may pose a problem
if the gene of interest is toxic to hepatocytes or can betiter of circulating virus and increase the exposure time
of renal glomerular cells to this vector. Our results clearly secreted into blood circulation. One possible strategy to
prevent the transgene expression in the liver would be todemonstrate that mouse renal glomerular cells could be
infected by using the portal clamping technique without use tissue-specific promoters, which are inactive in hepat-
ocytes. In addition, new vectors could be developed withinducing significant liver injury [24]. Moreover, gene ex-
pression in renal glomeruli persisted for at least 42 days, a specific affinity to cell surface receptors expressed in
renal glomerular cells. For example, efficient adenoviraltherefore providing several weeks for the evaluation of
the effects of foreign genes in mouse renal glomerular gene transfer to kidney cortical cells has been recently
accomplished by using a modified vector with a high af-cells. It should be mentioned, however, that when the
portal clamping is released after 30 minutes, the circulat- finity to the v integrin, which is preferentially expressed
in vascular endothelial cells [15]. Overall, the current re-ing rAds enter the liver and infect hepatocytes. A previ-
ous study has shown that when the liver is infected with nal infusion protocol, if combined with the use of tissue-
specific promoters and modified adenoviral vectors, mayan adenovirus carrying the lacZ gene, -galactosidase
protein produced in the hepatocytes could be released into be a powerful tool for the evaluation of the biological ef-
fects of different genes in renal glomerular cells.the circulation as a result of immune attack on transduced
hepatocytes. The protein is transported and trapped al- Finally, the kidney infusion technique could be easily
adapted to human applications. In humans, the infusionmost exclusively in kidney glomeruli [39]. Thus, to con-
firm that the positive lacZ staining in the glomeruli of can be carried out through renal artery without blocking
blood flow in the aorta. Moreover, the issue of viral spread-mice subjected to the portal clamping infusion protocol
was the result of virus-mediated -galactosidase expres- ing into the liver could be easily prevented by selectively
Ye et al: Gene transfer to renal glomeruliS-22
vivo kidney perfusion system - first steps towards gene therapy ofperfusing the kidney with virus in a closed-circuit system,
Alport syndrome. Gene Ther 3:21–27, 1996as was performed by Heikkila et al in pig kidneys, or 9. Lipkowitz M, Hanss B, Tulchin N, et al: Transduction of renal
by perfusing the kidney before transplantation [8]. This cells in vitro and in vivo by adeno-associated virus gene therapy
vectors. J Am Soc Nephrol 10:1908–1915, 1999study shows that all renal glomerular cells are equally sus-
10. Lai L, Moeckel G, Lien Y: Kidney-targeted liposome-mediatedceptible to the infection with Ad vectors and suggests
gene transfer in mice. Gene Ther 4:426–431, 1997
that rAd vectors may be useful tools to treat human 11. Tomita N, Higaki J, Morishita R, et al: Direct in vivo gene intro-
duction into rat kidney. Biochem Biophys Res Commun 186:129–glomerular diseases. However, the renal cytotoxic and
134, 1992immunogenic effects of rAd vectors need to be thor-
12. Akami T, Arakawa K, Okamoto M, et al: Introduction and expres-oughly studied before these vectors are used in humans, sion of human CD59 gene in the canine kidney. Transplant Proc
and the techniques described in this study may validate 26:1315–1316, 1994
13. Imai E, Isaka Y, Akagi Y, Kaneda Y: Gene transfer into thethe use of rodents for this purpose.
glomerulus by hemagglutinating virus of Japan (HVJ)-liposomeIn summary, kidney-oriented gene transfer techniques
method. Exp Nephrol 5:112–117, 1997
are still in their formative stages. Current viral delivery 14. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced
by in vivo transfection of transforming growth factor- or plateletsystems must be refined to allow efficient and persistent
derived growth factor gene into the rat kidney. J Clin Invest 92:transgene expression while avoiding toxicity and immune
2597–2601, 1993
response. Tissue specificity and regulated gene expression 15. McDonald G, Zhu G, Li Y, et al: Efficient adenoviral gene transfer
are also the desirable features of an ideal gene delivery to kidney cortical vasculature utilizing a fiber modified vector.
J Gene Med 1:103–120, 1999system. We believe that the portal clamping and pro-
16. Lipkowitz M, Klotman M, Bruggeman L, et al: Molecular therapylonged renal infusion techniques will facilitate the use for renal diseases. Am J Kidney Dis 28:475–492, 1996
of rodents as small animal model systems to study the 17. Sukhatme V, Cowley B, Zhu G: Gene transfer into kidney tu-
bules and vasculature by adenoviral vectors. Exp Nephrol 5:137–efficacy and safety issues related to the transfer of foreign
143, 1997genes into renal glomerular cells using rAd-vectors.
18. Moullier P, Salvetti A, Champion-Arnaud P, Ronco P: Gene
Hopefully, these techniques may also be useful to de- transfer into the kidney: Current status and limitations. Nephron
77:139–151, 1997velop new animal models of renal glomerular diseases
19. Imai E, Akagi Y, Isaka Y: Towards gene therapy for renal diseases.and to study the process of renal development.
Nephrologie 19:397–402, 1998
20. Kitamura M, Fine L: Gene transfer into the adult kidney for
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